May 06, 2020
The Patent Trial and Appeal Board has wiped out part of an Antecip Bioventures II LLC joint pain treatment patent as invalid due to earlier medical journal articles, rejecting Antecip's arguments that the articles were not sufficient to qualify as prior art.